A Review on SIRtuins in Diabetes.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Current pharmaceutical design

• Publication date

  2017-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/1381612823666170125153334PMID 28128062
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sirtuin-1 regulation of mammalian metabolism.

  2011cited by this paper
• Genetics of type 2 diabetes: pathophysiologic and clinical relevance

  2011cited by this paper
• Nuclear receptors linking circadian rhythms and cardiometabolic control.

  2010cited by this paper
• Nutrient-dependent regulation of PGC-1alpha's acetylation state and metabolic function through the enzymatic activities of Sirt1/GCN5.

  2010cited by this paper
• Study of 1,4-dihydropyridine structural scaffold: discovery of novel sirtuin activators and inhibitors.

  2009cited by this paper
• SIRT1 genetic variation and mortality in type 2 diabetes: interaction with smoking and dietary niacin.

  2009cited by this paper
• AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity

  2009cited by this paper
• Human Sirt-1: Molecular Modeling and Structure-Function Relationships of an Unordered Protein

  2009cited by this paper
• Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation.

  2009cited by this paper
• PGC-1α, SIRT1 and AMPK, an energy sensing network that controls energy expenditure

  2009cited by this paper
• SIRT1 Modulation of the Acetylation Status, Cytosolic Localization, and Activity of LKB1

  2008cited by this paper
• Negative regulation of the deacetylase SIRT1 by DBC1

  2008cited by this paper
• Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt.

  2008cited by this paper
• Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation.

  2008cited by this paper
• Sirt1 protects against high-fat diet-induced metabolic damage

  2008cited by this paper
• Tissue-specific regulation of SIRT1 by calorie restriction.

  2008cited by this paper
• SIRT1 Regulates Hepatocyte Lipid Metabolism through Activating AMP-activated Protein Kinase*

  2008cited by this paper
• Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC‐1α

  2007cited by this paper
• Active regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activity.

  2007cited by this paper
• AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha.

  2007cited by this paper
• SIRT1 sumoylation regulates its deacetylase activity and cellular response to genotoxic stress

  2007cited by this paper
• Phosphorylation of HuR by Chk2 regulates SIRT1 expression.

  2007cited by this paper
• SIRT1 deacetylates and positively regulates the nuclear receptor LXR.

  2007cited by this paper
• Metformin increases the PGC-1alpha protein and oxidative enzyme activities possibly via AMPK phosphorylation in skeletal muscle in vivo.

  2006cited by this paper
• Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage

  2006cited by this paper
• SIRT1 Regulates Adiponectin Gene Expression through Foxo1-C/Enhancer-binding Protein α Transcriptional Complex*

  2006cited by this paper
• Transgenic mice overexpressing nuclear SREBP-1c in pancreatic beta-cells.

  2005cited by this paper
• ER stress and SREBP-1 activation are implicated in beta-cell glucolipotoxicity.

  2005cited by this paper
• Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1.

  2005cited by this paper
• FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction.

  2005cited by this paper
• Sirt1 Regulates Insulin Secretion by Repressing UCP2 in Pancreatic β Cells

  2005cited by this paper
• PGC-1alpha coactivates PDK4 gene expression via the orphan nuclear receptor ERRalpha: a mechanism for transcriptional control of muscle glucose metabolism.

  2005cited by this paper
• Calorie restriction, SIRT1 and metabolism: understanding longevity

  2005cited by this paper
• Adiponectin and adiponectin receptors.

  2005cited by this paper
• Adipose tissue, inflammation, and cardiovascular disease.

  2005cited by this paper
• Regulation of muscle GLUT4 enhancer factor and myocyte enhancer factor 2 by AMP-activated protein kinase.

  2005cited by this paper
• Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses.

  2005cited by this paper
• Peroxisome Proliferator-activated Receptor-γ Co-activator 1α-mediated Metabolic Remodeling of Skeletal Myocytes Mimics Exercise Training and Reverses Lipid-induced Mitochondrial Inefficiency*

  2005cited by this paper
• Increased dosage of mammalian Sir2 in pancreatic beta cells enhances glucose-stimulated insulin secretion in mice.

  2005cited by this paper
• Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

  2004cited by this paper
• Role of uncoupling protein-2 up-regulation and triglyceride accumulation in impaired glucose-stimulated insulin secretion in a beta-cell lipotoxicity model overexpressing sterol regulatory element-binding protein-1c.

  2004cited by this paper
• SREBPs suppress IRS-2-mediated insulin signalling in the liver

  2004cited by this paper
• Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans.

  2004cited by this paper
• The estrogen-related receptor alpha (ERRalpha) functions in PPARgamma coactivator 1alpha (PGC-1alpha)-induced mitochondrial biogenesis.

  2004cited by this paper
• Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin.

  2004cited by this paper
• Erralpha and Gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle.

  2004cited by this paper
• The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes

  2003cited by this paper
• Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction.

  2003cited by this paper
• Sir2 regulation by nicotinamide results from switching between base exchange and deacetylation chemistry.

  2003cited by this paper
• Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1

  2003cited by this paper
• Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001.

  2003cited by this paper
• Effects of AICAR and exercise on insulin-stimulated glucose uptake, signaling, and GLUT-4 content in rat muscles.

  2003cited by this paper
• Protein Tyrosine Phosphatase 1B Attenuates Growth Hormone-Mediated JAK2-STAT Signaling

  2003cited by this paper
• Integrated analysis of protein composition, tissue diversity, and gene regulation in mouse mitochondria.

  2003cited by this paper
• Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan

  2003cited by this paper
• Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis.

  2003cited by this paper
• Activation of AMP kinase enhances sensitivity of muscle glucose transport to insulin.

  2002cited by this paper
• Conserved Enzymatic Production and Biological Effect of O-Acetyl-ADP-ribose by Silent Information Regulator 2-like NAD+-dependent Deacetylases*

  2002cited by this paper
• PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice

  2002cited by this paper
• Inhibition of Silencing and Accelerated Aging by Nicotinamide, a Putative Negative Regulator of Yeast Sir2 and Human SIRT1*

  2002cited by this paper
• Restoration of insulin-sensitive glucose transporter (GLUT4) gene expression in muscle cells by the transcriptional coactivator PGC-1

  2001cited by this paper
• Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1

  2001cited by this paper
• Independent influences of central fat and skeletal muscle lipids on insulin sensitivity.

  2001cited by this paper
• New perspectives into the molecular pathogenesis and treatment of type 2 diabetes.

  2001cited by this paper
• The Coactivator PGC-1 Cooperates with Peroxisome Proliferator-Activated Receptor α in Transcriptional Control of Nuclear Genes Encoding Mitochondrial Fatty Acid Oxidation Enzymes

  2000cited by this paper
• Silent information regulator 2 family of NAD- dependent histone/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose.

  2000cited by this paper
• Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1.

  1999cited by this paper
• Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene.

  1999cited by this paper
• Caloric restriction reverses hepatic insulin resistance in aging rats by decreasing visceral fat.

  1998cited by this paper
• The role of the liver in metabolic homeostasis: implications for inborn errors of metabolism.

  1991cited by this paper
• The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus.

  1963cited by this paper

• The Role of Inflammation in the Pathogenesis of Diabetic Peripheral Neuropathy: New Lessons from Experimental Studies and Clinical Implications

  2025cites this paper
• Harnessing SIRT1 activators for effective PCOS treatment: A new frontier.

  2025cites this paper
• High-intensity interval training (HIIT) ameliorates cardiac hypertrophy and fibrosis in diabetic rats: the role of P53 and SIRT1

  2025cites this paper
• Hesperetin protects against rotenone-induced motor disability and neurotoxicity via the regulation of SIRT1/NLRP3 signaling

  2024cites this paper
• Role of SIRT-1 as a target for treatment and prevention of Diabetic Nephropathy: A Review.

  2023cites this paper
• MiR-184 Mediated the Expression of ZNF865 in Exosome to Promote Procession in the PD Model

  2023cites this paper
• Evaluation of Rosuvastatin Therapy on SIRT1 Gene Expression in Patients with Multiple Sclerosis: An Uncontrolled Clinical Trial

  2023cites this paper
• A pharmacological review on SIRT 1 and SIRT 2 proteins, activators, and inhibitors: Call for further research.

  2023cites this paper
• Noninvasive Positron Emission Tomography Imaging of SIRT1 in a Model of Early-Stage Alcoholic Liver Disease.

  2023cites this paper
• Regulation of Gene Expression through Food—Curcumin as a Sirtuin Activity Modulator

  2022cites this paper
• Potential of Polyphenols to Restore SIRT1 and NAD+ Metabolism in Renal Disease

  2022cites this paper
• Rutaecarpine Prevents High Glucose-Induced Endothelial Cell Senescence Through Transient Receptor Potential Vanilloid Subtype 1/ SIRT1 Pathway

  2021cites this paper
• Ginsenoside Rg1 promoted the wound healing in diabetic foot ulcers via miR-489-3p/Sirt1 axis.

  2021cites this paper
• Nigella sativa as a promising intervention for metabolic and inflammatory disorders in obese prediabetic subjects: A comparative study of Nigella sativa versus both lifestyle modification and metformin.

  2021cites this paper
• Sirt1 and Sirt3 Activation Improved Cardiac Function of Diabetic Rats via Modulation of Mitochondrial Function

  2021cites this paper
• Elucidation of Structural Determinants Delineates the Residues Playing Key Roles in Differential Dynamics and Selective Inhibition of Sirt1-3

  2021cites this paper
• Targeting sirtuins to modulate energy metabolism in heart disease

  2021cites this paper
• Selenite supplementation modulates the hepatic metabolic sensors AMPK and SIRT1 in binge drinking exposed adolescent rats by avoiding oxidative stress.

  2021cites this paper
• Sirtuins in mechanistic target of rapamycin complex 1 signaling

  2021cites this paper
• Nrf2 signaling pathway in cisplatin chemotherapy: Potential involvement in organ protection and chemoresistance.

  2021cites this paper
• Association Between SIRT1, Cytokines, and Metabolic Syndrome in Schizophrenia Patients With Olanzapine or Clozapine Monotherapy

  2020cites this paper
• Exploring the Comparative Efficacy of Metformin and Resveratrol in the Management of Diabetes-Associated Complications: A Systematic Review of Preclinical Studies

  2020cites this paper
• The Serum Concentration of Anti-Aging Proteins, Sirtuin1 and αKlotho in Patients with End-Stage Kidney Disease on Maintenance Hemodialysis

  2020cites this paper
• Yin Yang 1 Is Essential for Transcriptional Activation of the Bovine Sirt2 Gene in Preadipocytes

  2020cites this paper
• Resveratrol in diabetes: benefits against oxidative stress in male reproduction

  2020cites this paper
• Protective effect of isoliquiritigenin on experimental diabetic nephropathy in rats: Impact on Sirt-1/NFκB balance and NLRP3 expression.

  2020cites this paper
• Genetic ablation of Fas-activated serine/threonine kinase ameliorates obesity-related hepatic glucose and lipid metabolic disorders via sirtuin-1 signaling.

  2020cites this paper
• Bartoli-Leonard, Francesca and Wilkinson, Fiona L and Langford-Smith, Alex WW and Alexander, MY and Weston, Ria (2018)The Interplay of SIRT1 and Wnt Signaling in Vascular Calcification. Frontiers in Cardiovascular Medicine, 5. ISSN 2297-055X

  2020cites this paper
• Curcumin alleviates oxidative stress and inhibits apoptosis in diabetic cardiomyopathy via Sirt1‐Foxo1 and PI3K‐Akt signalling pathways

  2020cites this paper
• SIRT1 Antagonizes Oxidative Stress in Diabetic Vascular Complication

  2020cites this paper
• Dilated cardiomyopathy impairs mitochondrial biogenesis and promotes inflammation in an age- and sex-dependent manner

  2020cites this paper
• CIA_A_236980 387..393

  2020cites this paper
• Sirtuin Inhibitors and Activators

  2019cites this paper
• Sirt5 Attenuates Cisplatin-Induced Acute Kidney Injury through Regulation of Nrf2/HO-1 and Bcl-2

  2019cites this paper
• A Preview of Selected Articles

  2019cites this paper
• SIRT1 Activation Promotes β‐Cell Regeneration by Activating Endocrine Progenitor Cells via AMPK Signaling‐Mediated Fatty Acid Oxidation

  2019cites this paper
• How could histone deacetylase activators be useful leads in the search for new therapeutics?

  2019cites this paper
• Overexpression of Sirt6 promotes M2 macrophage transformation, alleviating renal injury in diabetic nephropathy

  2019cites this paper
• IN SILICO STUDY OF SIRT1 ACTIVATORS USING A MOLECULAR DYNAMIC APPROACH

  2019cites this paper
• GABAergic regulation of pancreatic islet cells: Physiology and antidiabetic effects

  2019cites this paper
• Obesity-induced upregulation of miR-361-5p promotes hepatosteatosis through targeting Sirt1.

  2018cites this paper
• Pediatric obesity: Current concepts.

  2018cites this paper
• The Interplay Between Cholesterol Metabolism and Intrinsic Ageing.

  2018cites this paper
• Trichostatin A inhibits deacetylation of histone H3 and p53 by SIRT6.

  2018cites this paper
• The Interplay of SIRT1 and Wnt Signaling in Vascular Calcification

  2018cites this paper
• A Preview of Selected Articles

  2018cites this paper
• Advances in Biomarkers and Insulin Therapy with Relevance to Reversal of Diabetes

  2018cites this paper
• High Levels of SIRT1 Expression as a Protective Mechanism Against Disease-Related Conditions

  2018cites this paper
• SIRT1 and SIRT6 Signaling Pathways in Cardiovascular Disease Protection

  2017cites this paper
• The impact of FOXO-1 to cardiac pathology in diabetes mellitus and diabetes-related metabolic abnormalities.

  2017cites this paper